Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA grants priority review to Repatha sBLA seeking to include cardiovascular data

July 28, 2017

Shanghai Fochon Pharmaceutical and Fochon Pharma patent SLC22A12 inhibitors

July 28, 2017

EC approves update to Victoza label

July 28, 2017

Akcea and Ionis submit MAA in Europe for volanesorsen

July 28, 2017

AntriaBio doses first patient in phase I study of AB-101

July 26, 2017

Intrarosa launched in U.S.

July 25, 2017

Evotec reaches milestone in endometriosis alliance with Bayer

July 25, 2017

Shanghai Fochon Pharmaceutical and Fochon Pharma divulge SLC22A12 inhibitors

July 25, 2017

Orchard Therapeutics' OTL-101 wins FDA rare pediatric disease designation

July 25, 2017

EMA committee issues new Day 180 list of outstanding issues for abaloparatide

July 24, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...